RXRX

Recursion Pharmaceuticals, Inc. - Class A Common Stock NASDAQ

Last close $4.27 as of 07 Oct 2026

Avg call return: +8.8%; +6.8% vs. index
Scored calls: 3
Channels: 3
Win Rate: 67%
Side taken: 2Buy 1Sell

3 scored calls · 3 channels · first tracked 14 Jul 2026

RXRX: tracked call record. Across the full tracked record, 3 of 3 published calls are scored, with an average call return of 8.76%. Scored calls were published from 14 Jul 2026 to 01 Sep 2026, measured from each entry price to its latest available close (price dates: 07 Oct 2026 to 07 Oct 2026). Average benchmark excess is 6.76 percentage points, based on 3 of the 3 scored calls only. Unscored calls are excluded from averages. Holding periods and price freshness vary. These are averages of directional call returns, not an investable portfolio return; fees, dividends and execution costs are not included.

Who is calling RXRX

Last 12 months · 2 buying · 1 selling

01 Ale's World of Stocks Buy Calls 1 Return +28.2% Show calls
1. 01 Sep 2026 Buy Entry $3.33 Now $4.27 +28.2% vs. index +26.2%
  AI-extracted call. Cite this call
  
  Now thankfully I purchased a very tiny amount well after that gigantic crash. So I feel totally fine, you know, holding this as a very small spec play for the future.
Full record for Ale's World of Stocks
02 Stocks Galore - Stock Picks & Investing Insights Buy Calls 1 Return +27.8% Show calls
1. 14 Jul 2026 Buy Entry $3.34 Now $4.27 +27.8% vs. index +24.5%
  AI-extracted call. Cite this call
  
  That is one of the reasons Cathie Wood continues investing in the company.
Full record for Stocks Galore - Stock Picks & Investing Insights
03 CNBC Television Sell Calls 1 Return −29.8% Show calls
1. 12 Aug 2026 Sell Entry $3.29 Now $4.27 −29.8% vs. index −30.4%
  AI-extracted call. Cite this call
  
  it better come up with something soon because right now all it is is coming up is losses
Full record for CNBC Television